Correlation Between Tuttle Capital and IShares Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tuttle Capital and IShares Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tuttle Capital and IShares Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tuttle Capital Management and iShares Biotechnology ETF, you can compare the effects of market volatilities on Tuttle Capital and IShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tuttle Capital with a short position of IShares Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tuttle Capital and IShares Biotechnology.

Diversification Opportunities for Tuttle Capital and IShares Biotechnology

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tuttle and IShares is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Tuttle Capital Management and iShares Biotechnology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Biotechnology ETF and Tuttle Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tuttle Capital Management are associated (or correlated) with IShares Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Biotechnology ETF has no effect on the direction of Tuttle Capital i.e., Tuttle Capital and IShares Biotechnology go up and down completely randomly.

Pair Corralation between Tuttle Capital and IShares Biotechnology

If you would invest  2,527  in Tuttle Capital Management on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Tuttle Capital Management or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

Tuttle Capital Management  vs.  iShares Biotechnology ETF

 Performance 
       Timeline  
Tuttle Capital Management 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tuttle Capital Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Tuttle Capital is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
iShares Biotechnology ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, IShares Biotechnology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Tuttle Capital and IShares Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tuttle Capital and IShares Biotechnology

The main advantage of trading using opposite Tuttle Capital and IShares Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tuttle Capital position performs unexpectedly, IShares Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Biotechnology will offset losses from the drop in IShares Biotechnology's long position.
The idea behind Tuttle Capital Management and iShares Biotechnology ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets